Research map: Dimensional effect profiles in treatment-resistant depression: A naturalistic, prospective head-to-head comparison of arTMS, esketamine nasal spray, and oral brexpiprazole

Back to the article

Papers in this map

  1. World Medical Association Declaration of Helsinki · 2013 · 30960 citations · Cited by this paper
  2. Schema mode profiles and lifetime suicide attempts in patients with mood disorders in full remission: A latent profile analysis · 2026 · Related
  3. mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists · Nanxin Li · 2010 · 2924 citations · Cited by this paper
  4. Association of healthy lifestyle and social determinants with depression and anxiety in elderly patients with chronic diseases · 2026 · Related
  5. NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons · Houman Homayoun · 2007 · 1275 citations · Cited by this paper
  6. Response to the commentary by Tundo et al. on “Pramipexole exposure and risk of incident gambling disorder in individuals with psychiatric disorders: A nationwide register-based cohort study” · 2026 · Related
  7. Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study · Vanina Popova · 2019 · 900 citations · Cited by this paper
  8. Psychiatric comorbidities in seborrheic dermatitis: A cross-sectional analysis using a multi-institute electronic health record database · 2026 · Related
  9. Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions · Roger S. McIntyre · 2023 · 805 citations · Cited by this paper
  10. Prenatal maternal distress and fetal heart rate: Examining sex-specific sensitivity · 2026 · Related
  11. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression · Ella Daly · 2019 · 790 citations · Cited by this paper
  12. Treatment-characteristic brain structural changes in depression: A multi-center longitudinal observational study · 2026 · Related
  13. Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study · Carla M. Canuso · 2018 · 678 citations · Cited by this paper
  14. Heart rate variability reactivity moderates the relationship between behavioral disinhibition and suicide attempts in mood disorders · 2026 · Related
  15. Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3 · Rachel Ochs-Ross · 2019 · 478 citations · Cited by this paper
  16. Exploratory analysis of the relationships of sleep disorders, emotional symptoms and blood inflammatory markers with suicidal ideation in major depressive disorder · 2026 · Related
  17. Management of Treatment-Resistant Depression: Challenges and Strategies · Daphne Voineskos · 2020 · 444 citations · Cited by this paper
  18. Next-Step Treatment Options for Treatment-Resistant Depression · 2026 · Related
  19. Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial · Michael F. Grunebaum · 2017 · 434 citations · Cited by this paper
  20. The clinical characterization of the adult patient with depression aimed at personalization of management · Mario Maj · 2020 · 428 citations · Cited by this paper
  21. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression · Amit N. Anand · 2023 · 275 citations · Cited by this paper
  22. Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression · Níall Lally · 2014 · 273 citations · Cited by this paper
  23. Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression · Andreas Reif · 2023 · 219 citations · Cited by this paper
  24. A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials · Luca Sforzini · 2021 · 213 citations · Cited by this paper
  25. Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study) · Giovanni Martinotti · 2022 · 143 citations · Cited by this paper
  26. Ketamine: Mechanisms and Relevance to Treatment of Depression · Ji‐Woon Kim · 2023 · 114 citations · Cited by this paper
  27. Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals · Anahit Mkrtchian · 2020 · 113 citations · Cited by this paper
  28. Perspectives for therapy of treatment‐resistant depression · Mariusz Papp · 2021 · 90 citations · Cited by this paper
  29. Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or Behavior · Carla M. Canuso · 2021 · 88 citations · Cited by this paper
  30. Thinking too much: rumination and psychopathology · Thomas W. Ehring · 2021 · 84 citations · Cited by this paper
  31. Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment‐resistant depression · Giovanni Martinotti · 2023 · 76 citations · Cited by this paper
  32. The effect of ketamine on anhedonia: improvements in dimensions of anticipatory, consummatory, and motivation-related reward deficits · Danica Nogo · 2022 · 53 citations · Cited by this paper
  33. Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review · Fabrice Jollant · 2023 · 53 citations · Cited by this paper
  34. The effect of esketamine in patients with treatment‐resistant depression with and without comorbid anxiety symptoms or disorder · Ella Daly · 2021 · 46 citations · Cited by this paper
  35. Brexpiprazole—Pharmacologic Properties and Use in Schizophrenia and Mood Disorders · Marcin Siwek · 2023 · 41 citations · Cited by this paper
  36. A meta-analysis of the effects of ketamine on suicidal ideation in depression patients · ZuoYao Shen · 2024 · 37 citations · Cited by this paper
  37. Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity · Ana Cecília Lucchese · 2021 · 36 citations · Cited by this paper
  38. Comparative effectiveness of repeated ketamine infusions in treating anhedonia in bipolar and unipolar depression · Wei Zheng · 2021 · 31 citations · Cited by this paper
  39. Ketamine treatment for anhedonia in unipolar and bipolar depression: a systematic review · Aleksander Kwaśny · 2024 · 26 citations · Cited by this paper

Source: OpenAlex (CC0)